뒤로
RemeGen Co., Ltd.(09995.HK) 가격
09995.HK 주가 차트
REMEGEN (09995.HK)
RemeGen Co., Ltd.
HK$93.95
-1.41%
$-1.34
장 종료: Jan 20, 16:00:00 HKT
주요 통계
이전 종가
$95.2
시가
$95.3
일일 범위
$92 - $95.8
52주 범위
$11.52 - $126.6
거래량
4.6M
평균 거래량
5.2M
EPS(TTM)
-2.35
배당수익률
--
시가총액
$19.5B
REMEGEN란 무엇인가요?
RemeGen Co Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Yantai, Shandong and currently employs 2,999 full-time employees. The company went IPO on 2020-11-09. RemeGen Co Ltd is a China-based company principally engaged in biopharmaceutical research, biopharmaceutical service, biopharmaceutical production and sale. The firm focuses on therapeutic antibody drugs such as antibody-drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies and bispecific antibodies. The Company’s main products include telitacicept, disitamab vedotin, RC28-E and others. The firm's products are mainly used to treat major diseases such as autoimmune diseases, oncology and ophthalmology. The firm mainly operates its businesses in the domestic and overseas markets.
